Market Cap 1.94B
Revenue (ttm) 5.78B
Net Income (ttm) 86.00M
EPS (ttm) N/A
PE Ratio 11.18
Forward PE 7.43
Profit Margin 1.49%
Debt to Equity Ratio 6.79
Volume 3,001,503
Avg Vol 2,847,768
Day's Range N/A - N/A
Shares Out 149.44M
Stochastic %K 11%
Beta 1.84
Analysts Sell
Price Target $22.40

Latest News on CC

The Long-Term Upside For Chemours Company After Q4 2024

Feb 19, 2025, 7:01 AM EST - 6 weeks ago

The Long-Term Upside For Chemours Company After Q4 2024


The Chemours Company (CC) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 11:06 AM EST - 6 weeks ago

The Chemours Company (CC) Q4 2024 Earnings Call Transcript


Chemours Announces First Quarter Dividend

Feb 14, 2025, 4:30 PM EST - 6 weeks ago

Chemours Announces First Quarter Dividend


Chemours Appoints Leslie M. Turner to its Board of Directors

Feb 11, 2025, 4:30 PM EST - 7 weeks ago

Chemours Appoints Leslie M. Turner to its Board of Directors


The Chemours Company (CC) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 11:25 AM EST - 5 months ago

The Chemours Company (CC) Q3 2024 Earnings Call Transcript


Chemours Announces Fourth Quarter Dividend

Oct 23, 2024, 4:15 PM EDT - 5 months ago

Chemours Announces Fourth Quarter Dividend


Top 7 Tax-Loss Stocks To Sell By October 31, 2024

Oct 21, 2024, 8:25 AM EDT - 5 months ago

Top 7 Tax-Loss Stocks To Sell By October 31, 2024

APO CELH CLF DG DLTR FIVE


Chemours: We're Back Down To Trough And A 'BUY'

Sep 1, 2024, 4:04 PM EDT - 7 months ago

Chemours: We're Back Down To Trough And A 'BUY'